Web Results


Gefitinib (ZD1839) is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the  ...


Gefitinib (Iressa) targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of non-small cell lung cancer.


IRESSA® (gefitinib) is a treatment for patients. ... IRESSA® gefitinib logo. For US Consumers; Go to US Healthcare Professional Site · Sign Up · Register · Go to ...


Gefitinib (Iressa). Read about gefitinib how you have it and what side effects it can have. Gefitinib is pronounced jeh-fit-ih-nib. It is also known by its brand name  ...


Dec 15, 2015 ... Gefitinib: learn about side effects, dosage, special precautions, and more on MedlinePlus.


Exposes the medication gefitinib (Iressa), a drug used as monotherapy for lung cancer that has not responded to chemotherapy.


Oct 5, 2006 ... This page contains brief information about gefitinib and a collection of links to more information about the use of this drug, research results, and ...


Easy to read patient leaflet for Gefitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.


Gefitinib (Iressa) also known as ZD-1839 & Iressa is a novel potent EGFR tyrosine kinase phosphorylation inhibitor with IC50 of 37, 26 and 57 nM. Find all the ...